Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Oesophageal Cancer-Reference-Cited by-同舟云学术

Evidence-based Guideline Recommendations on the use of Positron Emission Tomography Imaging in Oesophageal Cancer

Published:2012-03 Issue:2 Volume:24 Page:86-104
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Wong R.,Walker-Dilks C.,Raifu A.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference35 articles.

1. Canadian cancer statistics 2010;Canadian Cancer Society/National Cancer Institute of Canada,2010

2. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers;Facey;Health Technol Assess,2007

3. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas;Kato;Anticancer Res,2005

4. Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer;Lowe;Mol Imaging Biol,2005

5. Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer;Duong;Eur J Nucl Med Mol Imaging,2006

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increasing Use of PET-CT, Neoadjuvant Treatment, Minimally Invasive Approach and Surgical Radicality in Esophageal Cancer Surgery are Associated with Improved Short- and Long-term Outcomes in Real-World Setting;Journal of Gastrointestinal Surgery;2022-02-25

2. Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment;Journal of Gastrointestinal Oncology;2021-08

3. The use of systematic review evidence to support the development of guidelines for positron emission tomography: a cross-sectional survey;European Radiology;2021-03-08

4. Cancer of the Esophagus;Abeloff's Clinical Oncology;2020

5. FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer;International Journal of Clinical Oncology;2019-03-12